Cost-effectiveness analysis of a first-line treatment with cadonilimab plus platinum-based chemotherapy with or without bevacizumab for persistent, recurrent, or metastatic cervical cancer in China: COMPASSION-16 trial. - Ding, Yiling; Wang, Chunping; Shu, Yamin; Wang, Jinglin; Zhang, Qilin (Journal of Pharmaceutical Policy & Practice, 2025)